Learning Objectives:

1. Describe the Biology of Her2 positive breast cancer

2. List new developments in treatment of metastatic Her2 positive breast cancer

3. Articulate novel approaches in early stage Her2 positive breast cancer

Session date: 
01/22/2021 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Olwen Hahn, MD